| 物质名称 | CAS登记号 | 物质唯一标识 | 分子式 | 异名/同义词 |
|---|---|---|---|---|
| ANDUSOMERAN | 2918977-08-7 | 4F9QRS7ZV2 | ANDUSOMERAN ANDUSOMERAN [INN] ANDUSOMERAN [WHO-DD] CX-038839 CX-038839 (COVID-19 OMICRON SUBVARIANT KRAKEN) PREFUSION SPIKE PROTEIN MRNA CX-038839 (COVID-19 OMICRON SUBVARIANT XBB.1.5) PREFUSION SPIKE PROTEIN MRNA CX-038839 OMICRON (XBB.1.5) MESSENGER RNA (MRNA), 5'-CAPPED, ENCODING A FULL-LENGTH, CODON-OPTIMISED PRE-FUSION STABILISED CONFORMATION VARIANT (K982P AND V983P) OF THE SARS-COV-2 (SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2) SPIKE (S) GLYCOPROTEIN (OMICRON VARIANT XBB.1.5; BASED UPON GISAID: EPI_ISL_15948646) FURTHER OPTIMIZED BY TWO ADDITIONAL STOP CODONS, FLANKED BY AN ARTIFICIAL 5' UNTRANSLATED REGION (UTR) AND A 3' UTR DERIVED FROM THE HUMAN ALPHA GLOBIN GENE (HBA1) MODIFIED TO CONTAIN AN IDENTIFICATION AND RATIO (IDR) SEQUENCE TO ENABLE IDENTIFICATION AND RELATIVE RATIO DETERMINATION OF INDIVIDUAL RNA COMPONENTS IN A MULTIVALENT MRNA VACCINE, AND TERMINATED BY A 3' POLYADENYLATION (POLYA) TAIL; CONTAINS N1-METHYLPSEUDOURIDINE INSTEAD OF URIDINE (ALL-U>M 1.PSI.) RNA (RECOMBINANT 5'-(M7G-(5'->5')-PPP-GM)-CAPPED ALL URIDINE->N1-METHYLPSEUDOURIDINE-SUBSTITUTED SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 PRE-FUSION SPIKE GLYCOPROTEIN (982-PROLINE,983-PROLINE) XBB.1.5 VARIANT PLUS 5'- AND 3'-UNTRANSLATED FLANKING REGION-CONTAINING POLY(A)-TAILED MESSENGER CX-038839), INNER SALT |